# Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients

> **NCT00929708** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 329 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** AZD3199
- **DRUG:** formoterol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00929708
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2014-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929708, "Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00929708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*